Published November, 2015
By Pier Paolo Di Fiore and Giorgio Scita
Publisher: John Wiley & Sons Ltd (Wiley-VCH Verlag GmbH)
Rating:
Availability: Contact supplier

A monumental, one-stop encyclopedia that provides access to the current knowledge on biological signaling at the molecular, cellular, and organismic level, integrating knowledge from many different sources. Essential for everyone working in cell biology and molecular medicine. .

---

Published November, 2015
By Raimund Mannhold, Hugo Kubinyi, Gerd Folkers, Kevin Park, Dominic Williams and Daniel Antoine
Publisher: John Wiley & Sons Ltd (Wiley-VCH Verlag GmbH)
Rating:
Availability: Contact supplier

Explains the rational approach to reducing drug toxicity and adverse effects, by a survey of modern methods as well as a discussion of future challenges facing the pharmaceuticals industry. Key knowledge for drug development professionals wanting to stay ahead of the competition.

---

Published November, 2015
By Dirk Trauner
Publisher: John Wiley & Sons Ltd (Wiley-VCH Verlag GmbH)
Rating:
Availability: Contact supplier

Many elegant and efficient total syntheses have been achieved using biomimetic pathways. This book highlights sucessful stories of biomimetic chemistry using several examples. It also covers reaction types, such as cycloadditions, sigmatropic rearrangements, C-C bond forming reactions, oxidations and reductions and biomimetic catalysis in depth.

---

Published August, 2015
By Doren Paal, John R. Marler and JR Marler
Publisher: John Wiley & Sons Ltd (Wiley-VCH Verlag GmbH)
Rating:
Availability: Available

---

Published July, 2015
By H. Muller and Hartwig Muller
Publisher: John Wiley & Sons Ltd (Wiley-VCH Verlag GmbH)
Rating:
Availability: Available

Covering the entire spectrum of medical gases, this ready reference offers a comprehensive overview of production, medical gas equipment, medical gas verification, and medical gas safety standards.

---

Published May, 2015
By Roland K. Hartmann, Albrecht Bindereif, Astrid Schon, Eric Westhof, Astrid Sch?n and RK Hartmann
Publisher: John Wiley & Sons Ltd (Wiley-VCH Verlag GmbH)
Rating:
Availability: Available

The second edition of a highly acclaimed handbook and ready reference. Unmatched in its breadth and quality, around 100 specialists from all over the world share their up-to-date expertise and experiences, including hundreds of protocols, complete with explanations, and hitherto unpublished troubleshooting hints.

---

Published April, 2015
By Robert A. Meyers and RA Meyers
Publisher: John Wiley & Sons Ltd (Wiley-VCH Verlag GmbH)
Rating:
Availability: Available

These two volumes contain a selection of updated articles from the acclaimed Meyers Encyclopedia of Molecular Cell Biology and Molecular Medicine, the most authoritative resource in cell and molecular biology, combined with new articles by "founding fathers" in the field.

---

Published April, 2015
By Raimund Mannhold, Hugo Kubinyi, Gerd Folkers, David Swinney, Gyorgy Keseru, David C. Swinney, Gyoergy Keseru and GM Keseru
Publisher: John Wiley & Sons Ltd (Wiley-VCH Verlag GmbH)
Rating:
Availability: Available

This practical reference for medicinal and pharmaceutical chemists combines the theory of binding kinetics & thermodynamics with modern experimental and computational methods as well as several case studies from recent lead finding and optimization projects.

---

Published April, 2015
By Michael Bauer, Jurgen Popp and J Popp
Publisher: John Wiley & Sons Ltd (Wiley-VCH Verlag GmbH)
Rating:
Availability: Available

This outstanding overview sets a new standard for a methods book on pathogen detection. The first chapter provides an outline of currently used routine methods, including their background, strengths and weaknesses, as well as comparing them to newer methods.

---

Published April, 2015
By Harald Seitz, Sarah Schumacher and H Seitz
Publisher: John Wiley & Sons Ltd (Wiley-VCH Verlag GmbH)
Rating:
Availability: Available

Built on a decade of experience with novel molecular diagnostics, this practice-oriented guide shows how to cope with validation issues during all stages of biomarker development, from the first clinical studies to the eventual commercialization of a new diagnostic test.

---